GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease (SLD), from ...

London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

A Cambridge biotech company is preparing to lay off its entire staff of more than 300 after being acquired by another firm.

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

Boston Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting New Phase 2 Clinical Data from BOS-580 NASH Program at EASL 2023 May 18, 2023 07:00 AM Eastern Daylight Time ...

Boston Pharmaceuticals To Present New Phase 2a Data From Investigational BOS-580 NASH Program at AASLD The Liver Meeting® 2023 November 07, 2023 09:44 AM Eastern Standard Time ...

Boston Pharmaceuticals today announces the appointment of Joanne Beck, Ph.D., as Chief Operating Officer. Dr. Beck joins Boston Pharmaceuticals from Celgene Corporation, where she was Executive ...

BOSTON, June 9, 2025 – The Renaissance Boston Seaport District recently debuted its stunning new rooms… Scouting America is proud to announce that Bob Rivers, Executive Chair and Chair of the ...

Novartis AG (NOVN.EB) said Wednesday that it entered into a licensing and equity agreement with Boston Pharmaceuticals to develop three anti-infective drug candidates that are part of the Swiss ...